PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting.

Mansi Saxena,

Thomas U Marron,

Julia Kodysh,

John P Finnigan,

Sayali Onkar,

Anna Kaminska,

Kevin Tuballes,

Ruiwei Guo,

Rachel Lubong Sabado,

Marcia Meseck,

Timothy J O'Donnell,

Robert P Sebra,

Samir Parekh,

Matthew D Galsky,

Ana Blasquez,

Gustavo Gimenez,

Mesude Bicak,

Cansu Cimen Bozkus,

Daniela Delbeau-Zagelbaum,

Denise Rodriguez,

Ana Acuna-Villaorduna,

Krzysztof J Misiukiewicz,

Marshall R Posner,

Brett A Miles,

Hanna Y Irie,

Amy Tiersten,

Deborah B Doroshow,

Andrea Wolf,

John Mandeli,

Rachel Brody,

Andres M Salazar,

Sacha Gnjatic,

Jeff Hammerbacher,

Eric Schadt,

Philip Friedlander,

Alexander Rubinsteyn,

Nina Bhardwaj